Mannkind (MNKD) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.43% |
| Dec 31, 2025 | -20.60% |
| Sep 30, 2025 | -37.60% |
| Jun 30, 2025 | -23.01% |
| Mar 31, 2025 | -36.22% |
| Dec 31, 2024 | -31.73% |
| Sep 30, 2024 | -38.20% |
| Jun 30, 2024 | -79.64% |
| Mar 31, 2024 | -38.37% |
| Dec 31, 2023 | -32.71% |
| Sep 30, 2023 | -66.64% |
| Jun 30, 2023 | -40.14% |
| Mar 31, 2023 | -43.57% |
| Dec 31, 2022 | -28.72% |
| Sep 30, 2022 | -75.19% |
| Jun 30, 2022 | -28.86% |
| Mar 31, 2022 | -27.62% |
| Dec 31, 2021 | -54.89% |
| Sep 30, 2021 | -31.37% |
| Jun 30, 2021 | -20.58% |
| Mar 31, 2021 | -58.52% |
| Dec 31, 2020 | -2.60% |
| Sep 30, 2020 | -9.87% |
| Jun 30, 2020 | 9.93% |
| Mar 31, 2020 | 20.30% |
| Dec 31, 2019 | 16.21% |
| Sep 30, 2019 | 21.92% |
| Jun 30, 2019 | 20.26% |
| Mar 31, 2019 | -10.64% |
| Dec 31, 2018 | -0.25% |
| Sep 30, 2018 | 34.89% |
| Jun 30, 2018 | 1.31% |
| Mar 31, 2018 | 0.56% |
| Dec 31, 2017 | 4.80% |
| Sep 30, 2017 | -36.44% |
| Jun 30, 2017 | -6.28% |
| Mar 31, 2017 | 3.29% |
| Dec 31, 2016 | -48.26% |
| Sep 30, 2016 | -8.81% |
| Jun 30, 2016 | -20.33% |
| Mar 31, 2016 | 10.03% |
| Dec 31, 2015 | 3.46% |
| Sep 30, 2015 | 19.59% |
| Jun 30, 2015 | -30.46% |